Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE-EPIC: Enalapril to enhance pulmonary rehabilitation in COPD
2012-000413-36Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of enalapril in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Imperial College London. Primary endpoint: Change in peak workload on cycle ergometer. Started Mar 2012; status: completed.
02
Drugs
enalapril
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-000413-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000413-36.